Journal of Clinical Medicine (Oct 2023)

Bile Acids Pneumonia: A Respiratory Distress Syndrome in Early-Term Neonates

  • Alessandro Perri,
  • Maria Letizia Patti,
  • Margherita Velardi,
  • Annamaria Sbordone,
  • Giorgia Prontera,
  • Simona Fattore,
  • Vito D’Andrea,
  • Milena Tana,
  • Giovanni Vento

DOI
https://doi.org/10.3390/jcm12206565
Journal volume & issue
Vol. 12, no. 20
p. 6565

Abstract

Read online

Intrahepatic cholestasis of pregnancy (ICP) complicates among 0.2–2% of pregnancies and has been associated with adverse perinatal outcomes, including sudden stillbirth, meconium strained fluid, preterm birth, perinatal asphyxia, and transient tachypnea of the newborn. The diagnosis of “bile acids pneumonia” was previously proposed and a causative role of bile acids (BA) was supposed with a possible mechanism of action including surfactant dysfunction, inflammation, and chemical pneumonia. In the last few years, the role of lung ultrasound (LUS) in the diagnosis and management of neonatal respiratory distress syndrome has grown, and LUS scores have been introduced in the literature, as an effective predictor of the need for surfactant treatment among neonates with respiratory distress syndrome. We present four cases of infants born from pregnancies complicated by ICP, who developed respiratory distress syndrome early after birth. Lung ultrasound showed the same pattern for all infants, corresponding to a homogeneous alveolar–interstitial syndrome characterized by a diffuse coalescing B-line pattern (white lung). All infants evaluated require non-invasive respiratory support and in three cases surfactant administration, despite the near-term gestational age, with rapid improvement of respiratory disease and a good clinical outcome.

Keywords